Marinova-Mutafchieva L, Taylor P, Funa K, Maini R N, Zvaifler N J
Kennedy Institute of Rheumatology, London, UK.
Arthritis Rheum. 2000 Sep;43(9):2046-55. doi: 10.1002/1529-0131(200009)43:9<2046::AID-ANR16>3.0.CO;2-8.
To evaluate the presence of cells of an early mesenchymal lineage, as judged by the expression of bone morphogenetic protein receptors (BMPRs), in the joints of normal individuals and patients with rheumatoid arthritis (RA).
Synovial fluids, single cell suspensions of cultured fibroblast-like synoviocytes (FLS), and synovial tissues were examined by immunohistology with antibodies to BMPR type IA (BMPRIA), BMPRIB, and BMPRII and then quantified using computerized image analysis. Other antibodies were evaluated by cytofluorography.
In primary cultures of joint effusions from patients with RA and other forms of inflammatory arthritis, there were large adherent cells with the appearance of either fibroblasts or stromal cells that stained with antibodies to mesenchymal elements-CD44, type I collagen, alpha-actin, and vimentin-but not with antibodies to hematopoietic markers. These cells proliferated rapidly, expressed BMPRIA and BMPRII, and soon became the predominant cells in culture. They were retained through multiple passages and persistently displayed surface vascular cell adhesion molecule 1. Immunohistochemical analysis of cultured RA FLS (passages 3, 4, and 6; n = 6) revealed that 11.6% were BMPR-positive, while only 2.0% of osteoarthritis FLS (passage 4; n = 3) were BMPR-positive, and 1 normal synovial culture had no BMPR-positive cells. In all RA synovial membranes examined (n = 9), BMPRI- and BMPRII-expressing cells were identified in the intimal lining and were also scattered in the subintima. These cells constituted approximately 25% and approximately 7% of the cells in each area, respectively. Double immunostaining showed no coexpression of BMPR-positive cells with CD68, CD34, or CD3. Cells expressing BMPR were not seen in any normal synovial samples (n = 4). Strong staining for BMPR was identified on cells at the invasive front of the pannus and at sites of cartilage erosion.
The inflamed RA joint contains BMPR-positive mesenchymal cells. Their origin is still speculative, but since their counterparts in the bone marrow are essential for osteoclastogenesis, support lymphocyte development and maturation, and protect T cells and B cells from programmed cell death, the BMPR-positive cells may be essential elements in the pathogenesis of RA and other inflammatory forms of chronic synovitis.
通过骨形态发生蛋白受体(BMPRs)的表达来评估正常个体和类风湿关节炎(RA)患者关节中早期间充质谱系细胞的存在情况。
采用抗IA型BMPR(BMPRIA)、BMPRIB和BMPRII抗体,通过免疫组织化学对滑液、培养的成纤维样滑膜细胞(FLS)单细胞悬液和滑膜组织进行检测,然后使用计算机图像分析进行定量。通过细胞荧光术评估其他抗体。
在RA患者和其他形式炎性关节炎患者的关节积液原代培养物中,有大量贴壁细胞,其形态为成纤维细胞或基质细胞,用间充质成分抗体(CD44、I型胶原、α - 肌动蛋白和波形蛋白)染色呈阳性,但用造血标志物抗体染色呈阴性。这些细胞增殖迅速,表达BMPRIA和BMPRII,很快成为培养物中的主要细胞。它们能传代多次,并持续表达表面血管细胞黏附分子1。对培养的RA FLS(第3、4和6代;n = 6)进行免疫组织化学分析显示,11.6%为BMPR阳性,而骨关节炎FLS(第4代;n = 3)中只有2.0%为BMPR阳性,1例正常滑膜培养物中无BMPR阳性细胞。在所有检测的RA滑膜组织(n = 9)中,在内膜衬里及散在于内膜下层均发现表达BMPRI和BMPRII的细胞。这些细胞分别约占每个区域细胞的25%和约7%。双重免疫染色显示BMPR阳性细胞与CD68、CD34或CD3无共表达。在任何正常滑膜样本(n = 4)中均未见到表达BMPR的细胞。在血管翳侵袭前沿的细胞以及软骨侵蚀部位的细胞上发现BMPR强染色。
炎症性RA关节含有BMPR阳性间充质细胞。它们的起源仍具有推测性,但由于其在骨髓中的对应细胞对破骨细胞生成至关重要,支持淋巴细胞发育和成熟,并保护T细胞和B细胞免于程序性细胞死亡,因此BMPR阳性细胞可能是RA及其他慢性滑膜炎炎症形式发病机制中的关键要素。